key emerging trials in cml and the importance of improving treatment-free remission rates
Published 9 months ago • 81 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:43
current research in waldenström’s macroglobulinemia
-
1:22
exciting upcoming mpns trials: v617f-targeted jak2 inhibitors and anti-calreticulin antibodies
-
3:19
key clinical trials in mds taking place in the us
-
0:45
key trials in cll and designing a concept for treatment
-
3:02
the effects of maintenance therapy on real-world outcomes for patients with ndmm
-
26:46
webinar recording | technology advances in hematology testing | sparrc 2021 by srmc | mindray india
-
5:04
monday minutes: licensing erm
-
30:53
hematology keywoord review 2019 - (dr. rebel)
-
2:25
key ebmt guideline updates for the treatment and prophylaxis of gvhd
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
1:23
developing a pro collection tool for patients with scd: key themes which are important to patients
-
2:10
key highlights from ebmt 2023
-
1:25
key changes in the hct survivorship guidelines
-
1:06
derive trial update: did vs dvd in newly diagnosed mm
-
1:29
updates on the diagnosis, risk stratification and management of hl
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:14
updates on the smart stop trial: the potential for a chemo-free regimen in the frontline for dlbcl
-
1:51
thrombotic and bleeding complications in al amyloidosis
-
0:57
the potential of the tsafinder tool in hematological oncology
-
1:08
the progress of the ebmt & key ongoing projects